Cargando…
Heart failure clinical care analysis uncovers risk reduction opportunities for preserved ejection fraction subtype
Heart failure (HF) has no cure and, for HF with preserved ejection fraction (HFpEF), no life-extending treatments. Defining the clinical epidemiology of HF could facilitate earlier identification of high-risk individuals. We define the clinical epidemiology of HF subtypes (HFpEF and HF with reduced...
Autores principales: | Levinson, Rebecca T., Vaitinidin, Nataraja Sarma, Farber-Eger, Eric, Roden, Dan M., Lasko, Thomas A., Wells, Quinn S., Mosley, Jonathan D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452678/ https://www.ncbi.nlm.nih.gov/pubmed/34545125 http://dx.doi.org/10.1038/s41598-021-97831-1 |
Ejemplares similares
-
Genetic Determinants of Body Mass Index and Fasting Glucose Are Mediators of Grade 1 Diastolic Dysfunction
por: Vaitinadin, Nataraja Sarma, et al.
Publicado: (2022) -
Characterizing a Clinical Trial – Representative, Real-World Population with Heart Failure with Reduced Ejection Fraction
por: Wells, Quinn S, et al.
Publicado: (2022) -
Heart Failure With Preserved Ejection Fraction: An Opportunity for Reflection
por: Gupta, Deepak K.
Publicado: (2017) -
New Opportunities in Heart Failure with Preserved Ejection Fraction: From Bench to Bedside… and Back
por: Parra-Lucares, Alfredo, et al.
Publicado: (2022) -
Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2019)